Bioera SpA
MIL:BIE
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.03
0.124
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Bioera SpA
Bioera SpA
Cash Equivalents
Bioera SpA
Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Bioera SpA
MIL:BIE
|
Cash Equivalents
€181k
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
|
|
Intercos SpA
MIL:ICOS
|
Cash Equivalents
€152.8m
|
CAGR 3-Years
-12%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
|
Pharmanutra SpA
MIL:PHN
|
Cash Equivalents
€6k
|
CAGR 3-Years
-94%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Enervit SpA
MIL:ENV
|
Cash Equivalents
€5.9m
|
CAGR 3-Years
829%
|
CAGR 5-Years
243%
|
CAGR 10-Years
N/A
|
|
Bioera SpA
Glance View
Bioera SpA is a holding company, which engages in the production and sale of organic products, natural cosmetics, and traditional food products. The company is headquartered in Milan, Milano and currently employs 3 full-time employees. The company went IPO on 2005-07-27. The company’s activities are divided into two sectors. The Biological and Natural products sector, through its subsidiaries and affiliated entities, is active in the distribution of natural and organic products; production of organic food from vegetables; manufacture of oil from organic agriculture, and distribution of traditional food products, as well as in the sector of natural origin cosmetics. The Holding sector provides activities of the Company as a parent of the group. The firm controls entities, such as Organic Oils Italia Srl, La Fonte della Vita Srl, KI Group SpA and Organic Food Retail Srl.
See Also
What is Bioera SpA's Cash Equivalents?
Cash Equivalents
181k
EUR
Based on the financial report for Jun 30, 2024, Bioera SpA's Cash Equivalents amounts to 181k EUR.
What is Bioera SpA's Cash Equivalents growth rate?
Cash Equivalents CAGR 5Y
-2%
Over the last year, the Cash Equivalents growth was -58%. The average annual Cash Equivalents growth rates for Bioera SpA have been -15% over the past three years , -2% over the past five years .
You don't have any saved screeners yet